Beike Biotechnology Co., Ltd.
Beike Biotechnology Co., Ltd., commonly referred to as Beike Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2005, the company has made significant strides in regenerative medicine, focusing on innovative cell therapies and advanced medical solutions. With a strong presence in major operational regions across Asia and beyond, Beike Biotech is renowned for its unique offerings, including umbilical cord blood stem cell therapies and personalised treatment plans. These core products stand out due to their commitment to safety and efficacy, positioning the company as a trusted name in the industry. Recognised for its pioneering research and development, Beike Biotech continues to achieve notable milestones, solidifying its market position as a frontrunner in the field of regenerative medicine.
DitchCarbon Score
How does Beike Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beike Biotechnology Co., Ltd.'s score of 20 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Beike Biotechnology Co., Ltd.'s reported carbon emissions
Beike Biotechnology Co., Ltd., headquartered in China, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biotechnology sector. As the industry increasingly focuses on sustainability, it is essential for companies like Beike to establish clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beike Biotechnology Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
